DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Relebactam
Relebactam
IDSA Guideline Review
Recarbrio, INN-Imipenem / Cilastatin / Relebactam
New Β-Lactamase Inhibitor Combinations: Options for Treatment; Challenges for Testing
AMEG Categorisation of Antibiotics
Title. 1 in Vitro Activity of the New Β-Lactamase Inhibitors Relebactam
Antibiotics Currently in Clinical Development
CLSI AST News Update Janet A
Antimicrobial Resistant Phenotype Definitions
In Vitro Studies Evaluating the Activity of Imipenem in Combination with Relebactam Against Pseudomonas Aeruginosa Katherine Young1* , Ronald E
Antibiotic Update
RECARBRIO, INN-Imipenem/Cilastatin/Relebactam
Antimicrobial Use and Resistance (AUR) Module
Stembook 2018.Pdf
Antibiotics Active Against Carbapenem-Resistant Gram-Negative Bacilli July 2021 (Including Enterobacterales and P
Newer Antibiotics: Need for More Studies in Neonates and Children Jeeson C Unni
Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria
New Antibiotic Approvals 2017-2019 Joshua Garcia, Pharmd, BCPS Assistant Professor, Marshall B
Treatment of Carbapenem Resistant Gram Negative Infections
Top View
Pharmacokinetics of Non-Β-Lactam Β-Lactamase Inhibitors
Discovery of Novel Chemical Series of OXA-48 -Lactamase Inhibitors By
ETEST® Strip Application Ensures Streamline Testing Andsaves Valuable Time
Antibiotic Formulations
Shionogi Briefing Document
Relebactam in Combination with Imipenem and Cilastatin for the Treatment of Drug Resistant Gram-Negative Infections
2020 Antibacterial Agents in Clinical and Preclinical
The Future of Β-Lactamase Inhibitors
Instructions to Authors
PRODUCT CATALOGUE 2021-2022 IVD Solutions Through Partnership
Update on New Research in Gram-Negative Infections European Congress of Clinical Microbiology and Infectious Diseases 2017 (22–25 April, Vienna, Austria)
Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/ Relebactam in Complicated Infections: a Meta-Analysis
Imipenem/Cilastatin/Relebactam (RECARBRIO) National Drug
Molecular Basis of Class a Β-Lactamase Inhibition by Relebactam Downloaded from 2
Effect of Amoxicillin in Combination with Imipenem-Relebactam
2019 Antibacterial Agents in Clinical Development
Assessment Report
Treatment of Infections Caused by Multidrug-Resistant Gram-Negative
EAU Guidelines on Urological Infections 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin
NCT Number: NCT02452047 Document Date: 11-Sep-2017 Product: MK-7655A 1 Protocol/Amendment No.: 013-03
The Role of the ID Pharmacist
Activity of Imipenem/Relebactam Against Clinical Isolates of P
HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do
Infectious Diseases
CLSI AST News Update Janet A
Standard and High Dose Antibiotic Dosing Regimens
Official Protocol Title: NCT Number: NCT03293485 Document Date
8/26/2020 1 Antibiotic Stewardship Successes and Opportunities in The
SADIA ALI, M.D INFECTIOUS DISEASE PARK NICOLLET 10/11/2019 Disclosures
Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections
Restricted Antimicrobials Requiring Ast Approval in Patients on Adult Services
Alternative and Experimental Therapies of Mycobacterium Abscessus Infections
ETEST® IMIPENEM/ RELEBACTAM (0.002/4 - 32/4 Μg/Ml)
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-To-Treat Resistance
Urinary Tract Infection in Women - Complicated (1 of 13)
Jason M. Pogue Email:
[email protected]
Education
Ceftazidime/Avibactam Allergan/Pfizer Approved February 25, 2015 EMA: June 2016 6
Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
Medchemcomm Accepted Manuscript
Document Details
Drug Specific Supplement for MTS™ Imipenem-Relebactam
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors
Prior Authorization Criteria for Approval
Activity of Imipenem/Relebactam Against Clinical Isolates of P